跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MYLAN-AZELASTINE/FLUTICASONE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MYLAN-AZELASTINE/FLUTICASONE
Authorized
STANDARD
MYLAN-AZELASTINE/FLUTICASONE
Mylan Pharmaceuticals ULC
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
fe3b8b858dd9b662
Company
Mylan Pharmaceuticals ULC
Type
Standard
Approval Details
Approval Id
fe3b8b858dd9b662
Drug Approval Canada Name
MYLAN-AZELASTINE/FLUTICASONE
Product Name
MYLAN-AZELASTINE/FLUTICASONE
Status
Marketed
Status Date
2023-08-16
Original Market Date
2023-08-16
Din
02530341
Drug Class
Human
Dosage Form
Spray, Metered Dose
Route Of Administration
Nasal
Schedule
Prescription
Ahfs
04:08.00
Atc Original
R01AD58 FLUTICASONE, COMBINATIONS
Atc Name
r 01 ad 58
Aig Number
0256150002
Company Name
Mylan Pharmaceuticals ULC
Company Address
85 Advance Road, Etobicoke, Ontario, Canada, M8Z 2S6
Active Ingredients
AZELASTINE HYDROCHLORIDE
137 MCG / ACT
FLUTICASONE PROPIONATE
50 MCG / ACT
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
fe3b8b858dd9b662
Type
Standard
Back to Health Canada Approvals